Capital Fund Management (CFM)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Capital Fund Management (CFM)’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-29,332	Closed	-$3.11M	–	2175
2019 Q4	$3.07M	Buy	29,332 +27,081	+1,203%	+$3.04M	0.02%	701
2019 Q3	$259K	Buy	+2,251	New	+$342K	﹤0.01%	1496
2018 Q4	–	Sell	-4,251	Closed	-$558K	–	2327
2018 Q3	$734K	Sell	4,251 -4,577	-52%	-$660K	﹤0.01%	1477
2018 Q2	$1.23M	Buy	+8,828	New	+$1.25M	0.01%	1259
2018 Q1	–	Sell	-51,236	Closed	-$6.76M	–	2288
2017 Q4	$6.76M	Buy	51,236 +30,254	+144%	+$3.55M	0.04%	551
2017 Q3	$2.13M	Buy	+20,982	New	+$2.25M	0.02%	754
2017 Q1	–	Sell	-151,691	Closed	-$18.6M	–	1946
2016 Q4	$17M	Buy	151,691 +141,850	+1,441%	+$17.1M	0.15%	193
2016 Q3	$1.31M	Buy	+9,841	New	+$941K	0.01%	884
2016 Q2	–	Sell	-3,550	Closed	-$256K	–	1880
2016 Q1	$256K	Buy	+3,550	New	+$195K	﹤0.01%	1370

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Fund Management (CFM)'s GWPH Position: Q1 2020 in Review

Capital Fund Management (CFM) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 29,332 shares — an estimated $3.11M sold.

Capital Fund Management (CFM) first reported a position in GWPH in Q1 2016 and held it in 9 quarters. The position peaked at $17M in Q4 2016. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Capital Fund Management (CFM) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Capital Fund Management (CFM) sold 29,332 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $3.11M.
Capital Fund Management (CFM) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 9 quarters.
Capital Fund Management (CFM)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $17M in Q4 2016.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2020, filed 13 May 2020.